Covid19
Conditions
Brief summary
Although the direct damage from the viruses contributes to the initiation of the disease, the cytokine storm caused by COVID-19 plays a vital role in the development of acute lung injury and adult respiratory distress syndrome. IL-6, a kind of pleiotropic cytokine, is expressed by immune cells such as DC, monocytes, macrophages, B cells, and subsets of activated T cells, as well as by non-immune cells like fibroblasts, epithelial cells, and keratinocytes
Detailed description
The World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a public health emergency of international concern the epidemic has put public health systems under severe strain both in western countries and in the developing world. SARS-CoV-2 displays a more efficient transmission pattern when compared with SARS-CoV and MERS-CoV. Although the direct damage from the viruses contributes to the initiation of the disease, the cytokine storm caused by COVID-19 plays a vital role in the development of acute lung injury and adult respiratory distress syndrome. IL-6, a kind of pleiotropic cytokine, is expressed by immune cells such as DC, monocytes, macrophages, B cells, and subsets of activated T cells, as well as by non-immune cells like fibroblasts, epithelial cells, and keratinocytes. It contributes to the pathogenesis of inflammatory or autoimmunity diseases. Excessive production of IL-6 leads to serious disease progression in viral infection. The IL-6 gene is located on chromosome 7 and several polymorphisms have been reported. The most frequently studied polymorphism is the single nucleotide polymorphism (SNP) 174C and - 174G in the promoter region, which has been associated with transcription rates of IL6. The incidence of IL-6-174C alleles is approximately 40%among the general Population. The G allele 174 SNP is coupled with the increased transcription upon endotoxin and IL-1β stimulation, IL-6 -174C allele carrier status is associated with higher level of IL-6 production and more severe forms of 4 pneumonia in general. This analysis strengthens the notion that IL-6 plays a pivotal role in novel coronavirus pneumonia (NCP) progression, it was IL-6-174 C allele rather than G allele that contributed to the risk of sepsis induced by Pneumonia
Interventions
Detection of IL6 level using ELISA technique.
The genotyping of the polymorphisms in IL-6 promoter G-174C (rs1800795) will be performed using PCR-RFLP technique.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients proved to be COVID-19 positive * clinical correlation with positive PCR. * clinical correlation with positive rapid antigen detection test.
Exclusion criteria
* Patients with chronic infections including hepatitis B or C infection. * Immunodeficiency virus (HIV) infections. * Autoimmune diseases including systemic lupus erthromatosus and rheumatoid arthritis. * Any malignancy or chronic inflammation * Any other chest diseases (TB)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| interleuken- 6 gene (174G/C) single nucleotide polymorphism | through study completion, an average of 4 months | the correlation between IL- 6 gene (174G/C) single nucleotide polymorphism with the pathogenesis of COVID-19 severity in Egyptian patients. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| interleukin 6 level | through study completion, an average of 4 months | the correlation between IL-6 with the pathogenesis of COVID-19 severity in Egyptian patients. |
Countries
Egypt